Tokyo

London

New York

Register

Sign In

EUR/USD

1.1193

0.0043

0.39%

GBP/USD

1.2720

0.0040

0.32%

USD/JPY

111.30

0.0070

0.01%

USD/CHF

0.9694

-0.0026

-0.26%

EUR/GBP

0.8800

0.0006

0.07%

USD/CAD

1.3269

0.0034

0.26%

NZD/USD

0.7281

0.0015

0.20%

EUR/JPY

124.58

0.4895

0.39%

EUR/CHF

1.0850

0.0014

0.13%

Cerulean Pharma Inc.

NASDAQ: CERUHealthcare / Biotechnology / USA
0.40+0.02+5.26%Vol 2 582 3531Y Perf -81.25%
Jun 23rd, 2017 16:00
BID0.41 ASK0.41
Open0.38 Previous Close0.38
Pre-Market- After-Trading-
 - -%  - -%
Target Price
1.50 
Analyst Rating
Moderate Buy 2.33
Potencial %
275.00 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
—    -
Market Cap (mil)11 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
2.45 
Earnings Date
3rd Aug 2017

Today's Price Range

0.380.44

 

52wk Range

0.323.58

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Buy
Performance
1 Month
-5.00%
3 Months
-66.07%
6 Months
-50.65%
1 Year
-81.25%
3 Years
-93.46%
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
CERU0.400.02005.26
AAPL146.350.72000.49
GOOG965.598.50000.89
MSFT71.210.95001.35
XOM81.610.53000.65
WFC52.45-0.0400-0.08
JNJ136.430.38000.28
FB155.071.67001.09
GE27.570.02000.07
JPM86.86-0.1600-0.18
...

TickerPriceChg.%52 Week High
EQT56.198.0080.61
AA31.094.3339.78
SWN5.794.3215.59
RRC22.263.8745.76
COG23.743.8526.74
WDC93.343.4295.00
TRIP36.963.4171.69
OKE49.192.9359.47
MOS22.972.9134.36
RIG8.092.8016.66
FCX11.762.7117.06
AKAM51.302.5671.64
ALGN153.502.55154.85
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.00
Current Ratio 2.30
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage -12.50
Leverage Ratio 2.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-1 518.40
EBITDA Margin-1 504.90
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.28
PS Ratios 5.05
Price to Cash Flow -
Price to Free Cash Flow -0.30
Cash Flow Per Share -1.08
Price to Tangible Book1.28
Book Value per Share0.27
Enterprise Value (in ths.)-2 134
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)210.78
ROE last 12 Months -146.84
Return on Assets (5Y Avg) -71.70
ROA last 12 Months -81.29
Return on Capital (5Y Avg) -
ROC last 12 Months -95.86
Return on invested Capital Q -33.11
Return on invested Capital Y-78.22
Assets Turnover0.00
Receivables Turnover0.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1 958
Revenue per Share 0.07
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2017-0.31-0.2229.03
Q03 2016-0.43-0.3616.28
Q02 2016-0.48-0.4016.67
Q01 2016-0.42-0.49-16.67
Q04 2015-0.38-0.39-2.63
Q03 2015-0.38-0.39-2.63
Q02 2015-0.40-0.377.50
Q01 2015-0.45-0.418.89
Earnings Per EndEstimateRevision %Trend
6/2017 QR-0.340.00-
9/2017 QR-0.370.00-
12/2017 FY-1.420.00-
12/2018 FY-1.430.00-
Next Report Date3rd Aug 2017
Estimated EPS Next Report-0.34
Estimates Count1
EPS Growth Next 5 Years %0.00
Volume Overview
Volume2 582 353
Shares Outstanding (in ths.)29 030
Trades Count1 277
Dollar Volume1 042 909
Avg. Volume2 485 060
Avg. Weekly Volume1 327 463
Avg. Monthly Volume620 116
Avg. Quarterly Volume1 072 377

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

45%55%

Bearish Bullish

55%45%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.33
Moderate Buy
2.33
Moderate Buy
2.33

There are no comments yet.

News

Plus500
x